Long-term survival of hamster hearts in presensitized rats

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4883-4892

  Lin, Yuan ^a,b   Soares, Miguel P ^b   Sato, Koichiro ^b   Csizmadia, Eva ^b   Robson, Simon C ^b   Smith, Neal ^c   Bach, Fritz H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; HAMSTER; HEART TRANSPLANTATION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TH2 CELL; XENOTRANSPLANTATION;

EID: 0034192081     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4883     Document Type: Article

References (64)

1. Hancock, W. W., M. L. Blakely, W. Van der Werf, and F. H. Bach. 1993. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-γ and diffuse endothelial activation. Transplant. Proc. 25:2932.
2. Blakely, M. L., W. Van der Werf, M. C. Berndt, A. P. Dalmasso, F. H. Bach, and W. W. Hancock. 1994. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059.
3. Leventhal, J. R., A. J. Matas, L. H. Sun, S. Reif, R. d. Bolman, A. P. Dalmasso, and J. L. Platt. 1993. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56:1.
4. Lin, S. S., B. C. Weidner, G. W. Byrne, L. E. Diamond, J. H. Lawson, C. W. Hoopes, L. J. Daniels, C. W. Daggett, W. Parker, R. C. Harland, et al. 1998. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101:1745.
5. Platt, J. L., B. J. Lindman, R. L. Geller, H. J. Noreen, J. L. Swanson, A. P. Dalmasso, and F. H. Bach. 1991. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 52:1037.
6. Inverardi, L., M. Samaja, R. Motterlini, F. Mangili, J. R. Bender, and R. Pardi. 1992. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immunol. 149:1416.
7. Itescu, S., P. Kwiatkowski, J. H. Artrip, S. F. Wang, J. Ankersmit, O. P. Minanov, and R. E. Michler. 1998. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum. Immunol. 59:275.
8. Davis, E. A., S. K. Pruitt, P. S. Greene, S. Ibrahim, T. T. Lam, J. L. Levin, W. r. Baldwin, and F, Sanfilippo. 1996. Inhibition of complement, evoked antibody. and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 62:1018.
9. Schmoeckel, M., F. N. Bhatti, A. Zaidi, K. Cozzi, P. D. Waterworth, M. J. Tolan, G. Pino-Chavez, M. Goddard, R. G. Warner, G. A. Langford, et al. 1998. Orthotopic heart transplantation in a transgenic pig-to-primate model. [Published erratum appears in 1998. Transplantation 66:943.] Transplantation 65:1570.
10. Kozlowski, T., A. Shimizu, D. Lambrigts, K. Yamada, Y. Fuchimoto, R. Glaser, R. Monroy, Y. Xu, M. Awwad, R. B. Colvin, et al. 1999. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 67:18.
11. Hasan, R., J.B. Van den Bogaerde, J. Wallwork, and D. J. White. 1992. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 54:408.
12. Murase, N., T. E. Starzl, A. J. Demetris, L. Valdivia, M. Tanabe, D. Cramer, and L. Makowka. 1993. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 55:701.
13. Chong, A. S., J. Shen, F. Xiao, L. Blinder, L. Wei, H. Sankary, P. Foster, and J. Williams. 1996. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 62:90.
14. Lin, Y., M. Vandeputte, and M. Waer. 1998. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Transplantation 65:332.
15. Bach, F. H., C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada, T. Miyatake, H. Winkler, A. Badrichani, D. Candinas, and W. W. Hancock. 1997. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. 3:196
16. Miyatake, T., N. Koyamada, W. W. Hancock, M. P. Soares, and F. H. Bach. 1998. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. Transplantation 65:1563.
17. Bach, F. H., M. A. Turman, G. M. Vercellotti, J. L. Platt, and A. P. Dalmasso. 1991. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant. Proc. 23:205.
18. Cramer, D. V. 1996. Natural Antibodies. Raver Press, New York.
19. Galili, U., R. E. Mandrell, R. M. Hamadeh, S. B. Shohet, and J. M. Griffiss. 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56:1730.
20. Kaplon, R. J., R. E. Michler, H. Xu, P. A. Kwiatkowski, N. M. Edwards, and J. L. Platt. 1995. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 59:1.
21. Gannedahl, G., P. A. Karlsson, A. Wallgren, E. E. Roos, B. Nilsson, T. H. Totterman, and G. Tufveson. 1994. Role of antibody synthesis and complement activation in concordant xenograft retransplantation. Transplantation 58: 337.
22. Lin, Y., M. Vandeputte, and M. Waer. 1997. Factors involved in rejection of concordant xenografts in complement-deficient rats. Transplantation 63:1705.
23. McCurry, K. R., W. Parker, A. H. Cotterell, B. C. Weidner, S. S. Lin, L. J. Daniels, Z. E. Holzknecht, G. W. Byrne, L. E. Diamond, J. S. Logan, and J. L. Platt. 1997. Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum. Immunol. 58:91.
24. H genes. Transplantation 66:1375.
25. Hechenleitner, P., W. Mark, D. Candinas, T. Miyatake, N. Koyamada, W. W. Hancock, and F. H. Bach. 1996. Protective genes expression in endothelial cells of second hamster heart transplanted to rats carrying an accommodated first graft. Xenotransplantation 3:279.
26. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:87.
27. Ferran, C., D. M. Stroka, A. Z. Badrichani, J. T. Cooper, C. J. Wrighton, M. Soares, S. T. Grey, and F. H. Bach. 1998. A20 inhibits NF-KB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91:2249.
28. Soares, M. P., A. Muniappan, E. Kaczmarek, K. Koziak, C. J. Wrighton, F. Steinhauslin, C. Ferran, H. Winkler, F. H. Bach, and J. Anrather. 1998. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J. Immunol. 161:4572.
29. L serve an anti-inflammatory function in endothelial cells through inhibition of NF-KB. J. Clin. Invest. 103:543.
30. Soares, M. P., Y. Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S. T. Grey, R. B. Colvin, A. M. Choi, K. D. Poss, and F. H. Bach. 1998. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4:1073.
31. Koyamada, N., T. Miyatake, D. Candinas, W. Mark, P. Hechenleitner, W. Hancock, M. Soares, and F. Bach. 1998 Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts. Transplantation 65:1210.
32. Naito, M., H. Nagai, S. Kawano, H. Umezu, H. Zhu, H. Moriyama, T. Yamamoto, H. Takatsuka, and Y. Takei. 1996, Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J. Leukocyte Biol. 60:337.
33. Mayer, M. 1961. Complement and Complement Fixation. Thomas, Springfield.
34. Lin, Y., M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, N. Smith, and F. H. Bach. 1999. Accommodated xenografts survive in the presence of antidonor antibodies and complement that precipitate rejection of naive xenografts. J. Immunol. 163:2850.
35. Lin, Y., G. Proud, R. M. Taylor, and J. A. Kirby. 1993. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens. Immunology 79:290.
36. Zarcone, D., A. B. Tilden, G. Cloud, H. M. Friedman, A. Landay, and C. E. Grossi. 1986. Flow cytometry evaluation of cell-mediated cytotoxicity. J. Immunol. Methods 94:247.
37. Miyatake, T., K. Sato, K. Takigami, N. Koyamada, W. W. Hancock, H. Bazin, D. Latinne, F. H. Bach, and M. P. Soares. 1998. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J. Immunol. 160:4114.
38. Chong, A. S., L. L. Ma, J. Shen, L. Blinder, D. P. Yin, and J. W. Williams. 1997. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation 64: 1650.
39. Brouard, S., G. Blancho, A. Moreau, J. M. Heslan, M. C. Cuturi, and J. P. Soulillou. 1998. Long-term survival of hamster-to-rat cardiac xenografts in the absence of a Th2 shift. Transplantation 65:1555.
40. Lin, Y., M. Vandeputte, and M. Waer. 1997. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J. Immunol. 158:5658.
41. Yin, D., L. L. Ma, L. Blinder, J. Shen, H. Sankary, J. W. Williams, and A. S. Chong. 1998. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J. Immunol. 161:2044.
42. Yang, Y. G., E. deGoma, H. Ohdan, J. L. Bracy, Y. Xu, J. Iacomini, A. D. Thall, and M. Sykes. 1998. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J. Exp. Med. 187:1335.
43. Candinas, D., S. Belliveau, N. Koyamada, T. Miyatake, P. Hechenleitner, W. Mark, F. H. Bach, and W. W. Hancock, 1996. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 62:1920.
44. Hasan, R. I., V. Sriwatanawangosa, J. Wallwork, and D. J. White. 1994. Graft adaptation in hamster-to-rat cardiac xenografts. Transplant. Proc. 26:1282.
45. Soares, M. P., Y. Lin, K. Sato, K. M. Stuhlmeier, and F. H. Bach. 1999. Accommodation. Immunol. Today 20:434.
46. Kobayashi, T., S. Taniguchi, F. A. Neethling, A. G. Rose, W. W. Hancock, Y. Ye, M. Niekrasz, S. Kosanke, L. J. Wright, D. J. White, and D. K. Cooper. 1997. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64:1255.
47. Pruitt, S. K., A. D. Kirk, R. R. Bollinger, H. J. Marsh, B. H. Collins, J. L. Levin, J. R. Mault, J. S. Heinle, S. Ibrahim, A. R. Rudolph, et al. 1994. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363.
48. Byrne, G. W., K. R. McCurry, D. Kagan, C. Quinn, M. J. Martin, J. L. Platt, and J. S. Logan. 1995. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice. Transplantation 60:1149.
49. Dalmasso, A. P., G. M. Vercellotti, J. L. Platt, and F. H. Bach. 1991. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 52:530.
50. Goodman, D. J., A. M. Von, A. Willson, M. T. Millan, and F. H. Bach. 1996. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 61:763.
51. Malyguine, A. M., S. Saadi, J. L. Platt, and J. R. Dawson. 1996. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 61:161.
52. Lin, Y., M. Vandepulte, and M. Waer. 1997. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 64:1677.
53. Murphy, B., H. J. Auchincloss, C. B. Carpenter, and M. H. Sayegh. 1996. T cell recognition of xeno-MHC peptides during concordant xenograft rejection. Transplantation 61:1133.
54. + T cells. J. Immunol. 162:1206.
55. Cupps, T. R., L. C. Edgar, and A. S. Fauci. 1982. Suppression of human B lymphocyte function by cyclophosphamide. J. Immunol. 128:2453.
56. Carobbi, A., D. Araneda, F. Thomas, P. Quarantillo, and J. Thomas. 1993. Splenectomy is a potent immunosuppressive modality for cardiac xenografting. Transplant. Proc. 25:419.
57. Johnson, E. M., R. J. Fischel, E. M. Boyle, A. J. Matas, and R. d. Bolman. 1992. Plasma exchange, splenectomy, and cyclophosphamide for natural antibody removal: kinetics and xenograft survival. Transplant. Proc. 24:701.
58. Miklos, K., M. Tolnay, H. Bazin, and G. A. Medgyesi. 1992. Antibody mediated lysis of bapten-conjugated target cells by macrophages and by complement: the influence of IgG subclass, antibody and hapten density. Mol. Immunol. 29:379.
59. Miklos, K., M. Tolnay, H. Bazin, and G. A. Medgyesi. 1993. Rat IgG subclasses mediating binding and phagocytosis of target cells by homologous macrophages. Mol. Immunol. 30:1273.
60. Thomas, F., D. Araneda, and P. Quarantillo. 1994. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation. Transplant. Proc. 26:1220.
61. Hancock, W. W., R. Buelow, M. H. Sayegh, and L. A. Turka. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4:1392.
62. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
63. Bach, F. H., H. Winkler, C. Ferran, W. W. Hancock, and S. C. Robson. 1996. Delayed xenograft rejection. Immunol. Today 17:379.
64. Hammer, C. 1998. Physiological obstacles after xenotransplantation. Ann. NY Acad. Sci. 862:19.